News & Press Releases
As many of you know, this past week marked the retirement of Byron Gross, whose legacy at NHeLP spanned the last 22 years. I would like to take a minute to reflect on that marvelous legacy.
NHeLP's former director, Larry Lavin, had the foresight to recruit Byron to join NHeLP's Board of Directors back in 1992, where he served for nearly 20 years, helping guide the organization through numerous developments in the health care field as well as internal changes—including the decision in 2008 to bring me on as executive director.
- RH Reality Check: How Virginia’s ‘Conscience Clause’ for Genetic Counselors Could Set a National Precedent
By Erin Matson
In August 2011, Liz Read-Katz was living in Texas, nearly 20 weeks pregnant, and was, in the words of the testimony she supplied to Planned Parenthood Advocates in Missouri, "ecstatic but scared as most soon-to-be parents are." Then her doctor told her that her blood work revealed she had a one-in-ten chance of having a child with trisomy 18. Also known as Edwards syndrome, trisomy 18 is a chromosomal condition that, according to the National Institutes of Health, causes "many individuals ... [to] die before birth or within the first month." This began the cascade of events that led Read-Katz to consult with a genetic counselor for additional information to support her during her very much wanted pregnancy.
The case for expanding access to the anti-overdose drug is gaining steam around the country. Here's how it works, where it's available and what comes next
By Nadja Popovich and Ruth Spencer
The death of actor Philip Seymour Hoffman from a heroin overdose in February cast a spotlight on America's steadily rising overdose rate. Since then, there's been a lot of reporting on how state governments are trying to address the problem. One popular move: making naloxone, a drug that can reverse opioid overdose, more widely available to the public.